首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
CeftazidimeAcquired drug resistance: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2025年
/ 2042卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-025-74910-8
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:111 / 111
相关论文
共 50 条
[31]
DaptomycinEmergence of drug resistance: case report
Reactions Weekly,
2019,
1776
(1)
: 150
-
150
[32]
LevofloxacinAcquired drug resistance: case report
Reactions Weekly,
2023,
1964
(1)
: 252
-
252
[33]
BevacizumabAcquired drug resistance: case report
Reactions Weekly,
2016,
1602
(1)
: 54
-
54
[34]
LamivudineDevelopment of drug resistance: case report
Reactions Weekly,
2019,
1758
(1)
: 212
-
212
[35]
NivolumabAcquired drug resistance: case report
Reactions Weekly,
2019,
1757
(1)
: 232
-
232
[36]
BedaquilineDevelopment of drug resistance: case report
Reactions Weekly,
2023,
1984
(1)
: 109
-
109
[37]
ErlotinibAcquired drug resistance: case report
Reactions Weekly,
2025,
2049
(1)
: 150
-
150
[38]
KanamycinAcquired drug resistance: case report
Reactions Weekly,
2019,
1765
(1)
: 209
-
209
[39]
GefitinibAcquired drug resistance: case report
Reactions Weekly,
2020,
1833
(1)
: 185
-
185
[40]
PralsetinibAcquired drug resistance: case report
Reactions Weekly,
2022,
1927
(1)
: 451
-
451
←
1
2
3
4
5
→